MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma.
Olivia SgarburaSophie GourgouDiego TosiNaoual BakrinNabila BouazzaStéphanie DelaineHélène De ForgesMarc PocardFrançois QuénetPublished in: Pleura and peritoneum (2019)
Prospective study. Clinicaltrials.gov: NCT03574493 EudraCT: 2019-001515-23.